VBI Vaccines
VBIV
#10527
Rank
S$2.41 M
Marketcap
S$0.08428
Share price
0.00%
Change (1 day)
-89.76%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): S-$13.65

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is S-$13.09. In 2022 the company made an earnings per share (EPS) of S-$17.04 a decrease over its 2021 EPS that were of S-$10.45.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$13.65
2022S-$17.0462.96%
2021S-$10.4528.57%
2020S-$8.13-54.35%
2019S-$17.81-52.58%
2018S-$37.5610.23%
2017S-$34.0714.29%
2016S-$29.82-62.8%
2015S-$80.1590.68%
2014S-$42.04-7.95%
2013S-$45.67-57.97%
2012S-$108.67-78%
2011S-$494.023151.47%
2010S-$15.1923.87%
2009S-$12.27-18.48%
2008S-$15.0512.08%
2007S-$13.43-49.47%
2006S-$26.57
2005N/A-100%
2004S-$11.8111.94%
2003S-$10.55-81.89%
2002S-$58.27196.44%
2001S-$19.6684.33%
2000S-$10.66-65.37%
1999S-$30.79-29.45%
1998S-$43.6429.61%
1997S-$33.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
S-$1.23-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S-$5.59-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S-$4.74-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA